Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Zhao B, Schwartz LH, Moskowitz CS, Ginsberg MS, Rizvi NA, Kris MG. Lung cancer: computerized quantification of tumor response--initial results. Radiology. 2006 Dec;241(3):892-8. doi: 10.1148/radiol.2413051887. PubMed PMID: 17114630.
Zhao B, Schwartz LH, Moskowitz CS, Wang L, Ginsberg MS, Cooper CA, Jiang L, Kalaigian JP. Pulmonary metastases: effect of CT section thickness on measurement--initial experience. Radiology. 2005 Mar;234(3):934-9. doi: 10.1148/radiol.2343040020. Epub 2005 Jan 28. PubMed PMID: 15681690.
Zhao B, Oxnard GR, Moskowitz CS, Kris MG, Pao W, Guo P, Rusch VM, Ladanyi M, Rizvi NA, Schwartz LH. A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development. Clin Cancer Res. 2010 Sep 15;16(18):4647-53. doi: 10.1158/1078-0432.CCR-10-0125. Epub 2010 Jun 9. PubMed PMID: 20534736; PubMed Central PMCID: PMC2940965.
Zhao B, James LP, Moskowitz CS, Guo P, Ginsberg MS, Lefkowitz RA, Qin Y, Riely GJ, Kris MG, Schwartz LH. Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer. Radiology. 2009 Jul;252(1):263-72. doi: 10.1148/radiol.2522081593. PubMed PMID: 19561260; PubMed Central PMCID: PMC2797680.
Zhao B, Schwartz LH, Jiang L, Colville J, Moskowitz C, Wang L, Leftowitz R, Liu F, Kalaigian J. Shape-constraint region growing for delineation of hepatic metastases on contrast-enhanced computed tomograph scans. Invest Radiol. 2006 Oct;41(10):753-62. doi: 10.1097/01.rli.0000236907.81400.18. PubMed PMID: 16971799.
Zhang Y, Wang VY, Morgan AE, Kim J, Handschumacher MD, Moskowitz CS, Levine RA, Ge L, Guccione JM, Weinsaft JW, Ratcliffe MB. Mechanical effects of MitraClip on leaflet stress and myocardial strain in functional mitral regurgitation - A finite element modeling study. PLoS One. 2019;14(10):e0223472. doi: 10.1371/journal.pone.0223472. eCollection 2019. PubMed PMID: 31600276; PubMed Central PMCID: PMC6786765.
Zhang J, Lefkowitz RA, Wang L, Ishill NM, Moskowitz CS, Russo P, Hricak H. Significance of peritumoral vascularity on CT in evaluation of renal cortical tumor. J Comput Assist Tomogr. 2007 Sep-Oct;31(5):717-23. doi: 10.1097/rct.0b013e318031521e. PubMed PMID: 17895782.
Zhang J, Lefkowitz RA, Ishill NM, Wang L, Moskowitz CS, Russo P, Eisenberg H, Hricak H. Solid renal cortical tumors: differentiation with CT. Radiology. 2007 Aug;244(2):494-504. doi: 10.1148/radiol.2442060927. PubMed PMID: 17641370.
Zhang J, Mironov S, Hricak H, Ishill NM, Moskowitz CS, Soslow RA, Chi DS. Characterization of adnexal masses using feature analysis at contrast-enhanced helical computed tomography. J Comput Assist Tomogr. 2008 Jul-Aug;32(4):533-40. doi: 10.1097/RCT.0b013e3181568890. PubMed PMID: 18664838.
Zakian KL, Hatfield W, Aras O, Cao K, Yakar D, Goldman DA, Moskowitz CS, Shukla-Dave A, Tehrani YM, Fine S, Eastham J, Hricak H. Prostate MRSI predicts outcome in radical prostatectomy patients. Magn Reson Imaging. 2016 Jun;34(5):674-81. doi: 10.1016/j.mri.2016.01.003. Epub 2016 Jan 26. PubMed PMID: 26821278; PubMed Central PMCID: PMC4860021.
Zakian KL, Hricak H, Ishill N, Reuter VE, Eberhardt S, Moskowitz CS, Shukla-Dave A, Wang L, Scardino PT, Eastham JA, Koutcher JA. An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy. J Urol. 2010 Dec;184(6):2320-7. doi: 10.1016/j.juro.2010.07.037. Epub 2010 Oct 16. PubMed PMID: 20952035; PubMed Central PMCID: PMC3074584.
Yu AF, Raikhelkar J, Zabor EC, Tonorezos ES, Moskowitz CS, Adsuar R, Mara E, Huie K, Oeffinger KC, Steingart RM, Liu JE. Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult Cancer. Biomed Res Int. 2016;2016:9363951. doi: 10.1155/2016/9363951. Epub 2016 Jan 28. PubMed PMID: 26942202; PubMed Central PMCID: PMC4749762.
Yu AF, Flynn JR, Moskowitz CS, Scott JM, Oeffinger KC, Dang CT, Liu JE, Jones LW, Steingart RM. Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast Cancer. JAMA Cardiol. 2020 Mar 1;5(3):309-317. doi: 10.1001/jamacardio.2019.5586. PubMed PMID: 31939997; PubMed Central PMCID: PMC6990842.
Yu AF, Moskowitz CS, Chuy KL, Yang J, Dang CT, Liu JE, Oeffinger KC, Steingart RM. Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy. JACC CardioOncol. 2020 Jun;2(2):166-175. doi: 10.1016/j.jaccao.2020.03.002. Epub 2020 Jun 16. PubMed PMID: 33103123; PubMed Central PMCID: PMC7584138.
Yu AF, Dang CT, Jorgensen J, Moskowitz CS, DeFusco P, Oligino E, Oeffinger KC, Liu JE, Steingart RM. Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy. Cardiooncology. 2023 Mar 9;9(1):13. doi: 10.1186/s40959-023-00163-4. PubMed PMID: 36895062; PubMed Central PMCID: PMC9996968.
Yu AF, Moore ZR, Moskowitz CS, Liu JE, Dang CT, Ramanathan L, Oeffinger KC, Steingart RM, Schmitt AM. Association of Circulating Cardiomyocyte Cell-Free DNA With Cancer Therapy-Related Cardiac Dysfunction in Patients Undergoing Treatment for ERBB2-Positive Breast Cancer. JAMA Cardiol. 2023 Jul 1;8(7):697-702. doi: 10.1001/jamacardio.2023.1229. PubMed PMID: 37256614; PubMed Central PMCID: PMC10233452.
Yeh JM, Lowry KP, Schechter CB, Diller LR, Alagoz O, Armstrong GT, Hampton JM, Leisenring W, Liu Q, Mandelblatt JS, Miglioretti DL, Moskowitz CS, Oeffinger KC, Trentham-Dietz A, Stout NK. Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study. Ann Intern Med. 2020 Sep 1;173(5):331-341. doi: 10.7326/M19-3481. Epub 2020 Jul 7. PubMed PMID: 32628531; PubMed Central PMCID: PMC7510774.
Yeh JM, Lowry KP, Schechter CB, Diller LR, O'Brien G, Alagoz O, Armstrong GT, Hampton JM, Hudson MM, Leisenring W, Liu Q, Mandelblatt JS, Miglioretti DL, Moskowitz CS, Nathan PC, Neglia JP, Oeffinger KC, Trentham-Dietz A, Stout NK. Breast Cancer Screening Among Childhood Cancer Survivors Treated Without Chest Radiation: Clinical Benefits and Cost-Effectiveness. J Natl Cancer Inst. 2022 Feb 7;114(2):235-244. doi: 10.1093/jnci/djab149. PubMed PMID: 34324686; PubMed Central PMCID: PMC8826394.
Wong FL, Lee JM, Leisenring WM, Neglia JP, Howell RM, Smith SA, Oeffinger KC, Moskowitz CS, Henderson TO, Mertens A, Nathan PC, Yasui Y, Landier W, Armstrong GT, Robison LL, Bhatia S. Health Benefits and Cost-Effectiveness of Children's Oncology Group Breast Cancer Screening Guidelines for Chest-Irradiated Hodgkin Lymphoma Survivors. J Clin Oncol. 2023 Feb 10;41(5):1046-1058. doi: 10.1200/JCO.22.00574. Epub 2022 Oct 20. PubMed PMID: 36265088; PubMed Central PMCID: PMC9928841.
Wibmer A, Vargas HA, Donahue TF, Zheng J, Moskowitz C, Eastham J, Sala E, Hricak H. Diagnosis of Extracapsular Extension of Prostate Cancer on Prostate MRI: Impact of Second-Opinion Readings by Subspecialized Genitourinary Oncologic Radiologists. AJR Am J Roentgenol. 2015 Jul;205(1):W73-8. doi: 10.2214/AJR.14.13600. PubMed PMID: 26102421.
Wibmer A, Hricak H, Gondo T, Matsumoto K, Veeraraghavan H, Fehr D, Zheng J, Goldman D, Moskowitz C, Fine SW, Reuter VE, Eastham J, Sala E, Vargas HA. Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. Eur Radiol. 2015 Oct;25(10):2840-50. doi: 10.1007/s00330-015-3701-8. Epub 2015 May 21. PubMed PMID: 25991476; PubMed Central PMCID: PMC5026307.
Wibmer A, Vargas HA, Sosa R, Zheng J, Moskowitz C, Hricak H. Value of a standardized lexicon for reporting levels of diagnostic certainty in prostate MRI. AJR Am J Roentgenol. 2014 Dec;203(6):W651-7. doi: 10.2214/AJR.14.12654. PubMed PMID: 25415731.
Weidman EK, Plodkowski AJ, Halpenny DF, Hayes SA, Perez-Johnston R, Zheng J, Moskowitz C, Ginsberg MS. Dual-Energy CT Angiography for Detection of Pulmonary Emboli: Incremental Benefit of Iodine Maps. Radiology. 2018 Nov;289(2):546-553. doi: 10.1148/radiol.2018180594. Epub 2018 Sep 11. PubMed PMID: 30204073; PubMed Central PMCID: PMC6209063.
Wang Y, Kremer LCM, van Leeuwen FE, Armstrong GT, Leisenring W, de Vathaire F, Hudson MM, Kuehni CE, Arnold MA, Haddy N, Demoor-Goldschmidt C, Diallo I, Howell RM, Ehrhardt MJ, Moskowitz CS, Neglia JP, van der Pal HJH, Robison LL, Schaapveld M, Turcotte LM, Waespe N, Ronckers CM, Teepen JC. Cohort profile: Risk and risk factors for female breast cancer after treatment for childhood and adolescent cancer: an internationally pooled cohort. BMJ Open. 2022 Nov 7;12(11):e065910. doi: 10.1136/bmjopen-2022-065910. PubMed PMID: 36344003; PubMed Central PMCID: PMC9644351.
Wang Y, Ronckers CM, van Leeuwen FE, Moskowitz CS, Leisenring W, Armstrong GT, de Vathaire F, Hudson MM, Kuehni CE, Arnold MA, Demoor-Goldschmidt C, Green DM, Henderson TO, Howell RM, Ehrhardt MJ, Neglia JP, Oeffinger KC, van der Pal HJH, Robison LL, Schaapveld M, Turcotte LM, Waespe N, Kremer LCM, Teepen JC. Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer. Nat Med. 2023 Sep;29(9):2268-2277. doi: 10.1038/s41591-023-02514-1. Epub 2023 Sep 11. PubMed PMID: 37696934; PubMed Central PMCID: PMC10504074.
Wang L, Zhang J, Schwartz LH, Eisenberg H, Ishill NM, Moskowitz CS, Scardino P, Hricak H. Incremental value of multiplanar cross-referencing for prostate cancer staging with endorectal MRI. AJR Am J Roentgenol. 2007 Jan;188(1):99-104. doi: 10.2214/ajr.05.1783. PubMed PMID: 17179351.
Vickers AJ, Cronin AM, Begg CB. One statistical test is sufficient for assessing new predictive markers. BMC Med Res Methodol. 2011 Jan 28;11:13. doi: 10.1186/1471-2288-11-13. PubMed PMID: 21276237; PubMed Central PMCID: PMC3042425.
Veiga LH, Curtis RE, Morton LM, Withrow DR, Howell RM, Smith SA, Weathers RE, Oeffinger KC, Moskowitz CS, Henderson TO, Arnold MA, Gibson TM, Leisenring WM, Neglia JP, Turcotte LM, Whitton JA, Robison LL, Armstrong GT, Inskip PD, Berrington de Gonzalez A. Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor Study. JAMA Pediatr. 2019 Dec 1;173(12):1171-1179. doi: 10.1001/jamapediatrics.2019.3807. PubMed PMID: 31657853; PubMed Central PMCID: PMC6820042.
Vargas HA, Akin O, Zheng J, Moskowitz C, Soslow R, Abu-Rustum N, Barakat RR, Hricak H. The value of MR imaging when the site of uterine cancer origin is uncertain. Radiology. 2011 Mar;258(3):785-92. doi: 10.1148/radiol.10101147. Epub 2011 Jan 6. PubMed PMID: 21212371; PubMed Central PMCID: PMC6939956.
Vargas HA, Akin O, Shukla-Dave A, Zhang J, Zakian KL, Zheng J, Kanao K, Goldman DA, Moskowitz CS, Reuter VE, Eastham JA, Scardino PT, Hricak H. Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. Radiology. 2012 Nov;265(2):478-87. doi: 10.1148/radiol.12120041. Epub 2012 Sep 5. PubMed PMID: 22952382; PubMed Central PMCID: PMC3480819.
Vargas HA, Akin O, Franiel T, Mazaheri Y, Zheng J, Moskowitz C, Udo K, Eastham J, Hricak H. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology. 2011 Jun;259(3):775-84. doi: 10.1148/radiol.11102066. Epub 2011 Mar 24. PubMed PMID: 21436085; PubMed Central PMCID: PMC3099046.
Vargas HA, Hötker AM, Goldman DA, Moskowitz CS, Gondo T, Matsumoto K, Ehdaie B, Woo S, Fine SW, Reuter VE, Sala E, Hricak H. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol. 2016 Jun;26(6):1606-12. doi: 10.1007/s00330-015-4015-6. Epub 2015 Sep 22. PubMed PMID: 26396111; PubMed Central PMCID: PMC4803633.
Vargas HA, Chaim J, Lefkowitz RA, Lakhman Y, Zheng J, Moskowitz CS, Sohn MJ, Schwartz LH, Russo P, Akin O. Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. Radiology. 2012 Sep;264(3):779-88. doi: 10.1148/radiol.12110746. Epub 2012 Jul 24. PubMed PMID: 22829683; PubMed Central PMCID: PMC6940015.
Vargas HA, Delaney HG, Delappe EM, Wang Y, Zheng J, Moskowitz CS, Tan Y, Zhao B, Schwartz LH, Hricak H, Russo P, Akin O. Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade. J Magn Reson Imaging. 2013 May;37(5):1160-7. doi: 10.1002/jmri.23899. Epub 2012 Nov 13. PubMed PMID: 23152173; PubMed Central PMCID: PMC3989993.
Vargas HA, Akin O, Afaq A, Goldman D, Zheng J, Moskowitz CS, Shukla-Dave A, Eastham J, Scardino P, Hricak H. Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer. J Urol. 2012 Nov;188(5):1732-8. doi: 10.1016/j.juro.2012.07.024. Epub 2012 Sep 25. PubMed PMID: 23017866; PubMed Central PMCID: PMC5617124.
Vargas HA, Schor-Bardach R, Long N, Kirzner AN, Cunningham JD, Goldman DA, Moskowitz CS, Sosa RE, Sala E, Panicek DM, Hricak H. Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis. Abdom Radiol (NY). 2017 Jan;42(1):271-277. doi: 10.1007/s00261-016-0851-3. PubMed PMID: 27480976; PubMed Central PMCID: PMC5247358.
Tringale KR, Casey DL, Niyazov G, Lavery JA, Moskowitz C, Friedman DN, Wolden SL. Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy: An updated analysis of more than 10 years of follow-up. Pediatr Blood Cancer. 2022 May;69(5):e29600. doi: 10.1002/pbc.29600. Epub 2022 Mar 2. PubMed PMID: 35234340; PubMed Central PMCID: PMC9476885.
Tringale KR, Gangai N, Chua A, Godwin K, Guman G, Laufer I, Cathcart KNS, Lis E, Schmitt A, Moskowitz CS, Chilov M, Vachha BA. Spine MRI Identifies Clinically Relevant Findings in Patients With Cancer Presenting With Back Pain. Spine (Phila Pa 1976). 2024 Mar 15;49(6):419-425. doi: 10.1097/BRS.0000000000004803. Epub 2023 Aug 21. PubMed PMID: 37602415; PubMed Central PMCID: PMC10879457.
Tonorezos ES, Snell PG, Moskowitz CS, Eshelman-Kent DA, Liu JE, Chou JF, Smith SM, Dunn AL, Church TS, Oeffinger KC. Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013 Aug;60(8):1358-64. doi: 10.1002/pbc.24492. Epub 2013 Feb 15. PubMed PMID: 23418044; PubMed Central PMCID: PMC3725590.
Tonorezos ES, Robien K, Eshelman-Kent D, Moskowitz CS, Church TS, Ross R, Oeffinger KC. Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia. Cancer Causes Control. 2013 Feb;24(2):313-21. doi: 10.1007/s10552-012-0116-6. Epub 2012 Nov 28. PubMed PMID: 23187859; PubMed Central PMCID: PMC3557541.
Tonorezos ES, Vega GL, Sklar CA, Chou JF, Moskowitz CS, Mo Q, Church TS, Ross R, Janiszewski PM, Oeffinger KC. Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. Pediatr Blood Cancer. 2012 Jan;58(1):31-6. doi: 10.1002/pbc.22964. Epub 2011 Jan 19. PubMed PMID: 21254377; PubMed Central PMCID: PMC3520427.
Tonorezos ES, Barnea D, Moskowitz CS, Chou JF, Sklar CA, Elkin EB, Wong RJ, Li D, Tuttle RM, Korenstein D, Wolden SL, Oeffinger KC. Screening for thyroid cancer in survivors of childhood and young adult cancer treated with neck radiation. J Cancer Surviv. 2017 Jun;11(3):302-308. doi: 10.1007/s11764-016-0588-6. Epub 2016 Dec 27. PubMed PMID: 28028762; PubMed Central PMCID: PMC5527324.
Thornton RH, Ulrich R, Hsu M, Moskowitz C, Reidy-Lagunes D, Covey AM, Brody LA, Robson PM, Sofocleous CT, Solomon SB, Getrajdman GI, Brown KT. Outcomes of patients undergoing percutaneous biliary drainage to reduce bilirubin for administration of chemotherapy. J Vasc Interv Radiol. 2012 Jan;23(1):89-95. doi: 10.1016/j.jvir.2011.09.022. Epub 2011 Nov 23. PubMed PMID: 22115568.
Sutton EJ, Watson EJ, Gibbons G, Goldman DA, Moskowitz CS, Jochelson MS, Dershaw DD, Morris EA. Incidence of Internal Mammary Lymph Nodes with Silicone Breast Implants at MR Imaging after Oncoplastic Surgery. Radiology. 2015 Nov;277(2):381-7. doi: 10.1148/radiol.2015142717. Epub 2015 Jun 18. PubMed PMID: 26098457; PubMed Central PMCID: PMC4976465.
Sung JS, Lebron L, Keating D, D'Alessio D, Comstock CE, Lee CH, Pike MC, Ayhan M, Moskowitz CS, Morris EA, Jochelson MS. Performance of Dual-Energy Contrast-enhanced Digital Mammography for Screening Women at Increased Risk of Breast Cancer. Radiology. 2019 Oct;293(1):81-88. doi: 10.1148/radiol.2019182660. Epub 2019 Aug 27. PubMed PMID: 31453765; PubMed Central PMCID: PMC6776233.
Sung JS, Jochelson MS, Brennan S, Joo S, Wen YH, Moskowitz C, Zheng J, Dershaw DD, Morris EA. MR imaging features of triple-negative breast cancers. Breast J. 2013 Nov-Dec;19(6):643-9. doi: 10.1111/tbj.12182. Epub 2013 Sep 9. PubMed PMID: 24015869.
Sogani J, Morris EA, Kaplan JB, D'Alessio D, Goldman D, Moskowitz CS, Jochelson MS. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging. Radiology. 2017 Jan;282(1):63-73. doi: 10.1148/radiol.2016160284. Epub 2016 Jul 4. PubMed PMID: 27379544; PubMed Central PMCID: PMC5207122.
Smith SM, Ford JS, Rakowski W, Moskowitz CS, Diller L, Hudson MM, Mertens AC, Stanton AL, Henderson TO, Leisenring WM, Robison LL, Oeffinger KC. Inconsistent mammography perceptions and practices among women at risk of breast cancer following a pediatric malignancy: a report from the Childhood Cancer Survivor Study. Cancer Causes Control. 2010 Oct;21(10):1585-95. doi: 10.1007/s10552-010-9587-5. Epub 2010 May 27. PubMed PMID: 20506037; PubMed Central PMCID: PMC2941535.
Shukla-Dave A, Hricak H, Moskowitz C, Ishill N, Akin O, Kuroiwa K, Spector J, Kumar M, Reuter VE, Koutcher JA, Zakian KL. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. Radiology. 2007 Nov;245(2):499-506. doi: 10.1148/radiol.2452062201. Epub 2007 Sep 21. PubMed PMID: 17890357.
Shukla-Dave A, Hricak H, Ishill NM, Moskowitz CS, Drobnjak M, Reuter VE, Zakian KL, Scardino PT, Cordon-Cardo C. Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer. Radiology. 2009 Mar;250(3):803-12. doi: 10.1148/radiol.2503080473. PubMed PMID: 19244047; PubMed Central PMCID: PMC2680166.
What would you like to do?